Automated Microbiology Market To Reach $13.73 Billion By 2030

Automated Microbiology Market Growth & Trends

The global automated microbiology market size is anticipated to reach USD 13.73 billion by 2030 and is anticipated to expand at a CAGR of 10.69% from 2025 to 2030, according to a new report by Grand View Research, Inc. The global automated microbiology market is expected to grow over the forecast period owing to the increasing prevalence of pathogen-induced diseases.

In recent years, the identification of pathogens with the help of automated microbiology has generated huge momentum, as it helps in the early detection of various infectious agents such as parasites, viroid, fungi, prion, bacterium, and viruses. These agents cause severe diseases like rubella, ebola, chickenpox, measles, mumps, influenza, and smallpox. Automated microbiology has gained importance as a result of outbreaks of new diseases as a consequence of adapting and mutating bacteria. The ability to promptly respond to the increasing demand for public health lies in offering accurate, better, and rapid identification of diseases and causative pathogens.

Rapid technological advancements are also boosting the growth of this market. For instance, the STEC test by BioControl Systems helps in the detection of non-O157 serotypes of E.coli with the help of molecular and food microbiology technology and BacT/ALERT 3D microbial detection system introduced by bioMeriux. As compared to other microbial detection systems, automated microbiology comes along with advantages such as early detection and an easy access system.

Recent industry developments underscore the market's dynamic nature. Companies are increasingly integrating artificial intelligence and machine learning into automated microbiology systems to enhance diagnostic accuracy and predict antimicrobial resistance patterns. Additionally, there's a notable shift towards molecular diagnostics, including techniques like polymerase chain reaction (PCR) and nucleic acid sequencing, offering rapid and specific microorganism detection. The COVID-19 pandemic has further accelerated the adoption of these automated solutions, highlighting their crucial role in scaling up testing capacities and reducing diagnostic turnaround times.

 Request a free sample copy or view report summary: Automated Microbiology Market Report

Automated Microbiology Market Report Highlights

• Based on product, reagents & kits segment dominated the market in 2024 owing to the growing demand for rapid and accurate microbial testing is driving the adoption of high-quality reagents and kits in automated microbiology. Advancements in molecular diagnostics, increasing antimicrobial resistance, and stringent regulatory requirements are further fueling market growth.

• Based on automation type, the fully automated segment dominated the market with the highest revenue share in 2024. The push for higher efficiency, reduced human errors, and faster turnaround times in microbial testing is accelerating the adoption of fully automated microbiology systems.

• Based on application, clinical diagnostics dominated the market with highest revenue share of 50.83% in 2024 and is expected to grow at a significant CAGR over the forecast period.

• Based on end use, the hospitals and diagnostic laboratories segment dominated the market with the highest revenue share in 2024, driven by the growing focus on infection control, antimicrobial stewardship, and cost-effective healthcare solutions is further driving market expansion in this segment.

• Based on region, the North America region dominated the automated microbiology market with a share of 41.29% in 2024 owing to factors such as the significant investments in research and development, coupled with the presence of key market players such as BD, Thermo Fisher Scientific, and bioMérieux, further propel market growth in North America.

Automated Microbiology Market Segmentation

Grand View Research has segmented the global automated microbiology market based on product, application, automation type, end-use, and region:

Automated Microbiology Product Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments    

  • Automated Microbial Identification Systems

  • Automated Blood Culture Systems

  • Automated Colony Counters

  • Automated Sample Preparation Systems

  • Automated Antibiotic Susceptibility Testing (AST) Systems

  • Other Instruments

• Reagents & Kits          

  • Culture Media

  • Stains & Dyes

  • Assay Kits & Panels

  • Others

• Software         

Automated Microbiology Automation Type Outlook (Revenue, USD Million, 2018 - 2030)

• Fully Automated

• Semi-Automated

Automated Microbiology Application Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical Production

• Clinical Diagnostics

• Environmental & Water Testing

• Food & Beverage Testing

• Other Applications

Automated Microbiology End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies

• Hospitals & Diagnostic Laboratories

• Academic & Research Institutes

• Other End Use

Automated Microbiology Regional Outlook (Revenue in USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Automated Microbiology Market

• BD

• QIAGEN

• Thermo Fisher Scientific Inc.

• Agilent Technologies, Inc.

• Danaher

• Merck KGaA

• bioMérieux

• Abbott

• DiaSorin S.p.A.

• BioRad Laboratories, Inc.